Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Napsin A staining in adrenal cortical neoplasms.

Ballard M, Sangoi A, McKenney JK, Troxell M.

Arch Pathol Lab Med. 2013 Jul;137(7):883. doi: 10.5858/arpa.2012-0583-LE. No abstract available.

PMID:
23808457
2.

Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.

Iqbal J.

Arch Pathol Lab Med. 2013 Feb;137(2):155. doi: 10.5858/arpa.2012-0123-LE. No abstract available.

PMID:
23368855
3.
4.

Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.

Johnson H, Cohen C, Fatima N, Duncan D, Siddiqui MT.

Acta Cytol. 2012;56(6):596-602. doi: 10.1159/000339793. Epub 2012 Nov 24.

PMID:
23207437
5.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
6.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
7.

Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.

Liu L, Cohen C, Siddiqui MT.

Acta Cytol. 2012;56(4):425-30. doi: 10.1159/000337439. Epub 2012 Jul 25.

PMID:
22846220
8.

Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.

Kim JH, Kim YS, Choi YD, Lee JS, Park CS.

Acta Cytol. 2011;55(3):266-70. doi: 10.1159/000326954. Epub 2011 Apr 27.

PMID:
21525739
9.

Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.

Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.

PMID:
21464700
10.

The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.

Li L, Li X, Yin J, Song X, Chen X, Feng J, Gao H, Liu L, Wei S.

PLoS One. 2014 Jul 8;9(7):e100837. doi: 10.1371/journal.pone.0100837. eCollection 2014.

11.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
12.

[Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].

Xu X, Liu H, Jiang H, Li C, Yuan S, Yang J.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Nov;35(11):1610-3. Chinese.

PMID:
26607085
13.

Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.

Dejmek A, Naucler P, Smedjeback A, Kato H, Maeda M, Yashima K, Maeda J, Hirano T.

Diagn Cytopathol. 2007 Aug;35(8):493-7.

PMID:
17636482
14.

TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.

Fatima N, Cohen C, Lawson D, Siddiqui MT.

Cancer Cytopathol. 2011 Apr 25;119(2):127-33. doi: 10.1002/cncy.20135. Epub 2011 Feb 1.

15.

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.

Ueno T, Linder S, Elmberger G.

Br J Cancer. 2003 Apr 22;88(8):1229-33.

16.

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J.

Clin Cancer Res. 2004 Jul 1;10(13):4314-24.

17.

The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.

Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK.

Cancer Cytopathol. 2010 Dec 25;118(6):441-9. doi: 10.1002/cncy.20108. Epub 2010 Sep 9.

18.

Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.

Agackiran Y, Ozcan A, Akyurek N, Memis L, Findik G, Kaya S.

Appl Immunohistochem Mol Morphol. 2012 Jul;20(4):350-5. doi: 10.1097/PAI.0b013e318245c730.

PMID:
22495379
19.

TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.

Porcel JM, Palma R, Bielsa S, Esquerda A, Gatius S, Matias-Guiu X, Salud A.

Respirology. 2015 Jul;20(5):831-3. doi: 10.1111/resp.12543. Epub 2015 Apr 14.

20.
Items per page

Supplemental Content

Write to the Help Desk